Copyright
©The Author(s) 2019.
World J Gastroenterol. Dec 14, 2019; 25(46): 6767-6780
Published online Dec 14, 2019. doi: 10.3748/wjg.v25.i46.6767
Published online Dec 14, 2019. doi: 10.3748/wjg.v25.i46.6767
Table 5 Diagnostic performance for invasion depth of SM2-3 or lesions indicated for surgery or chemoradiotherapy by fluorodeoxyglucose positron emission tomography alone
Invasion depth of SM2-3 | Lesions indicated for surgery or CRT | P value | |
Sensitivity | 93.3% (14/15) | 78.3% (18/23) | 0.37 |
Specificity | 77.6% (52/67) | 81.4% (48/59) | 0.60 |
PPV | 48.2% (14/29) | 62.1% (18/29) | 0.29 |
NPV | 98.1% (52/53) | 90.6% (48/53) | 0.12 |
Accuracy | 80.5% (66/82) | 80.5% (66/82) | 1.00 |
- Citation: Toriyama K, Tajika M, Tanaka T, Ishihara M, Hirayama Y, Onishi S, Mizuno N, Kuwahara T, Okuno N, Matsumoto S, Sasaki E, Abe T, Yatabe Y, Hara K, Matsuo K, Tamaki T, Niwa Y. Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma. World J Gastroenterol 2019; 25(46): 6767-6780
- URL: https://www.wjgnet.com/1007-9327/full/v25/i46/6767.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i46.6767